Tag: Misrepresentations

  • Corporate Law Expert Witness’ Testimony About the Role of Some CEOs is Entirely Irrelevant

    Corporate Law Expert Witness’ Testimony About the Role of Some CEOs is Entirely Irrelevant

    Plaintiffs, ECB USA, Inc. and Atlantic Ventures Corp. accused Savencia and Zausner, together with other persons and entities, of commiting a series of tortious acts, including, but not limited to, looting the assets of Schratter Foods Incorporated (“Schratter”), then fraudulently inducing Plaintiffs into executing an agreement to purchase all of Schratter’s shares (the “Stock Purchase Agreement”).

    Knowing that the ECB representatives had no experience with cheese and dairy products and were not eligible to work in the United States, Savencia and Zausner, along with other co-conspirators, induced the ECB Representatives to enter a fiduciary relationship with Alain Voss, and then induced Plaintiffs to partner with Voss in the purchase of Schratter. The ECB Representatives, and ultimately Plaintiffs, put their trust and confidence in Voss, who, in turn, colluded with Zausner, Savencia and other co-conspirators in the commission of frauds and other tortious acts.

    A key issue in the case is whether, prior to Schratter’s sale, Defendants secretly “stripped” Schratter’s Chief Executive Officer Voss of certain of his powers and duties as CEO and then “lied” to Plaintiffs’ by holding “Voss out as Schratter’s trusted, knowledgeable, and effective chief, for the purpose of persuading [Plaintiffs’] representatives to accept Voss as a fiduciary and to partner with him to purchase Schratter.

    Plaintiffs hired Jonathan Macey to provide “opinions on corporate governance and ordinary and customary corporate behavior.” Defendants filed a Daubert motion to exclude Macey’s opinions and testimony because his opinions were unreliable and did not “fit” the facts of the case.

    On March 22, 2024, Magistrate Judge Christopher Burke issued a memorandum order granting Defendants’ Daubert motion (“the Order”).

    Objections to the Order

    The order determined that Macey’s opinions did not fit the facts of the case because they were neither relevant nor would assist the trier of fact. Plaintiffs filed objections to the order on April 5, 2024. On April 19, 2024, Defendants filed a response to Plaintiffs’ objections. Pursuant to Federal Rule of Civil Procedure 72(a), the Court now considers the objections and responses and may “modify or set aside any part of the order that is clearly erroneous or is contrary to law.”

    Corporate Law Expert Witness

    Jonathan R. Macey is Sam Harris Professor of Corporate Law, Corporate Finance, and Securities Law at Yale University and Professor in the Yale School of Management. Professor Macey earned his B.A. cum laude from Harvard in 1977, and his J.D. from Yale Law School in 1982, where he was Article and Book Review editor of The Yale Law Journal.  In 1996, Professor Macey received a Ph.D. honoris causa from the Stockholm School of Economics. 

    Professor Macey has taught at major universities throughout the world, including Bocconi University (Milan), the University of Tokyo; the University of Toronto; the University of Turin, the University of Amsterdam Department of Finance, and the Stockholm School of Economics, Department of Law. He also has been Professor of Law at the University of Chicago (1990) and Visiting Professor of Law at Harvard Law School (1999). In 1998, he received the D.P. Jacobs prize for the most significant paper in volume 6 of the Journal of Financial Intermediation for his paper (co-authored with Maureen O’Hara), “The Law & Economics of Best Execution.”

    Get insight into every aspect of Jonathan R. Macey’s challenged expert witness experience – from direct testimony exclusions to affidavits supporting key motions – all covered in our Challenge Study. 

    Discussion by the Court

    Macey provided two principal opinions in his report:

    1. Based on commonly understood conceptions on the role of the CEO in business organizations such as [Schratter], Alain Voss was not actually the CEO of Schratter during the period beginning June 30, 2014 and continuing through December 31, 2014, as the term ‘CEO’ is universally understood in business. During the foregoing period Voss was the CEO of Schratter in name only, without the usual responsibilities, authority, and duties associated with that position.”
    2.  Analysis of the quality of management of the company being acquired (the target company) is a critical consideration in making a corporate acquisition where the acquisition is being done with management in place. An inevitable implication of this analysis is that the identity of a company’s CEO should be fully and accurately disclosed, including, but not limited to, in the governing documents of the target company. To the extent that a selling entity makes disclosures about the quality of management, such disclosures should be accurate.”

    Analysis

    Although Plaintiffs argued that Macey’s opinion is “necessary for the jury to fully understand the role of a CEO as that term is used in business,’ Macey’s opinion about the role of some CEOs did not relate to a “pertinent inquiry in the case.” 

    Plaintiffs asserted that the order misinterpreted Plaintiffs’ allegations about Voss, “erroneously found that Macey’s opinions regarding the importance of senior management, including a CEO, in an acquisition with management in place, are irrelevant,” and “made an unfounded assumption that a lay person would know what a CEO’s role and duties truly are in business.”

    The pertinent inquiry in this case is whether Defendants are liable for fraudulent misrepresentations or omissions made about Voss’s pre-closing role. To answer that inquiry, the jury will need to know what Voss’s role at Schratter was throughout 2014, if that role changed, and “the extent to which facts about Voss’s role were disclosed to Plaintiffs.”

    The Court held that information about what CEOs do, generally, is entirely irrelevant as to whether Defendants made material misrepresentation about Voss’s role.

    Additionally, to succeed on their fraud claims, Plaintiffs must prove that Defendants’ misrepresentations about Voss’s role were material to Plaintiffs’ decision to retain Voss.

    The order concluded that Macey’s opinion could not aid jurors in assessing the materiality element because Macey cannot opine on whether the alleged omissions and misstatements about Voss’s role were important to the specific Plaintiffs in this case. The Court held that Macey was not involved in the decision to retain Voss and thus cannot testify as to the state of mind of those who made the decision. Instead, it is only Plaintiffs, and Plaintiffs’ fact witnesses, who can prove that the alleged misrepresentations and omissions were material to their decision to retain Voss.

    Held

    The Court overruled the Plaintiffs’ objections to Magistrate Judge Christopher Burke’s memorandum order with regard to the testimony of Jonathan Macey.

    Key Takeaway:

    The Court agreed with Christopher Burke’s thorough analysis on the issue. To begin with, Macey’s opinion about the role of some CEOs did not relate to a “pertinent inquiry in the case.” Information about what CEOs do, generally, is entirely irrelevant as to whether Defendants made material misrepresentation about Voss’s role.

    Moreover, Macey was not involved in the decision to retain Voss and thus cannot testify as to the state of mind of those who made the decision. 

    Please refer to the blogs previously published about this case:

    Case Details:

    Case Caption: Ecb Usa, Inc. Et Al V. Savencia, S.A. Et Al
    Docket Number: 1:19cv731
    Court: United States District Court, Delaware
    Order Date: February 10, 2025
  • Insurance Expert Witness’ Opinions About Considering Ten Years’ Worth of Medical Records Rejected

    Insurance Expert Witness’ Opinions About Considering Ten Years’ Worth of Medical Records Rejected

    A district judge in Georgia barred certain opinions of an life insurance industry expert because no authority, underwriting or otherwise, was cited in support of such opinions.

    This case is about whether Pacific Life was entitled to rescind two life insurance policies and deny claims for benefits under them when it learned during the contestable claim period that Jimmie Long (“Mr. Long”) made material misrepresentations about his history of, and treatment for, abusing alcohol. Plaintiff Ronald Blalock (“Plaintiff”) owned, and was the beneficiary under, both policies. The policies were issued in January 2022, approximately four months before Long died in a car accident. Seven days after Long’s death, his insurance producer submitted claims for the benefits provided for in the policies. In accordance with the policies’ terms, Pacific Life conducted a contestable claim investigation—a routine action taken when an insured dies within two years of a policy’s issuance—to determine if the benefits were payable.

    Long’s medical records and Pacific Life’s investigation revealed that Long made material misrepresentations in his applications for insurance coverage. Pacific Life accordingly decided to rescind the policies and deny Plaintiff’s claims. Apparently dissatisfied with Pacific Life’s decisions, Plaintiff commenced this lawsuit. Plaintiff asserted claims for breach of contract and bad faith failure to pay benefits against Pacific Life.

    Plaintiff identified Vera Dolan as an expert witness to support his
    claims. Plaintiff asked Dolan to investigate two issues. He asked her to investigate Pacific Life’s contestable claim review of the two policies to determine if the review was fair, reasonable, and consistent with the standard of care. He also asked Dolan “to investigate the denial of claim payment to Long’s policies beneficiary, Ronald Blalock.”

    Insurance Expert Witness

    Vera Dolan has been involved in the life insurance industry as an underwriter for over 41 years, since 1982.  She is one of the leading mortality experts in the life insurance industry. She writes underwriting manuals and policy and procedure manuals for life and health insurance companies.

    Get the full story on challenges to Vera Dolan’s expert opinions and testimony with an in-depth Challenge Study. 

    Discussion by the Court

    Dolan, addressed the question of whether the medical records warranted Pacific Life’s finding of material “alcohol abuse” and concluded that “Long’s underwriting profile was not consistent with the profile of an alcohol abuser as defined by Pacific Life’s underwriting guidance.”

    Dolan opined that “Pacific Life is falsely stating that reviewing ten years of medical records at time of claim is fair and justified, when only five years of the most contemporaneous medical records were reviewed at time of issue without any finding of alcohol abuse.” Pacific Life argued that Dolan’s opinion was based on “speculation” and “unreliable principles and methods.”

    The Court held that Dolan cited no authority, underwriting or otherwise, supporting this opinion. Dolan did not dispute that it was appropriate to ask Long about his medical history for the ten years preceding his application for insurance. Nor did she dispute that Pacific Life could appropriately rely on the truthfulness of the information Long provided when it issued the Policies.

    When Long died within the contestable period, the only means available to confirm the accuracy of that information was to request records from the providers who saw Long during that ten-year period.

    Held

    The Court excluded Dolan’s opinion regarding the consideration of ten years’ worth of medical records. Her other opinions were limited pursuant to the parties’ consent.

    Key Takeaway:

    Vera Dolan argued that Pacific Life’s practice of reviewing ten years of medical records at the time of claim, despite only reviewing five years at the time of policy issuance, was not fair or justified​. She added that Long’s underwriting profile was not consistent with the profile of an alcohol abuser as defined by Pacific Life’s underwriting guidance. The Court, however, rejected her opinion regarding the consideration of ten years’ worth of medical records.

    Case Details:

    Case Caption: Blalock V. Pacific Life Insurance Company
    Docket Number: 5:23cv14
    Court: United States District Court, Georgia Middle
    Order Date: July 09, 2024